Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant Phase 2b in Primary Insomnia
NCT00792298Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of suvorexant in Insomnia, sponsored by Merck & Co.. Started Nov 2008; status: completed.
02
Drugs
suvorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00792298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792298.